These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38554933)

  • 1. Hormonal contraceptive use after a first venous thrombotic event and the risk of recurrence in premenopausal women.
    Verlaan JPL; Stegeman BH; Timp JF; Scheres LJJ; Flinterman LE; Helmerhorst FM; Rosendaal FR; Cannegieter SC; van Hylckama Vlieg A
    J Thromb Haemost; 2024 Aug; 22(8):2195-2202. PubMed ID: 38554933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of recurrent venous thromboembolism in patients with HIV infection: A nationwide cohort study.
    Rokx C; Borjas Howard JF; Smit C; Wit FW; Pieterman ED; Reiss P; Cannegieter SC; Lijfering WM; Meijer K; Bierman W; Tichelaar V; Rijnders BJA;
    PLoS Med; 2020 May; 17(5):e1003101. PubMed ID: 32407386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness and safety of rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolism.
    Coleman CI; Bunz TJ; Turpie AGG
    Thromb Haemost; 2017 Oct; 117(10):1841-1847. PubMed ID: 28640322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy use.
    Martinelli I; Lensing AW; Middeldorp S; Levi M; Beyer-Westendorf J; van Bellen B; Bounameaux H; Brighton TA; Cohen AT; Trajanovic M; Gebel M; Lam P; Wells PS; Prins MH
    Blood; 2016 Mar; 127(11):1417-25. PubMed ID: 26696010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type of Combined Contraceptives, Factor V Leiden Mutation and Risk of Venous Thromboembolism.
    Hugon-Rodin J; Horellou MH; Conard J; Gompel A; Plu-Bureau G
    Thromb Haemost; 2018 May; 118(5):922-928. PubMed ID: 29614525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonoral combined hormonal contraceptives and thromboembolism: a systematic review.
    Tepper NK; Dragoman MV; Gaffield ME; Curtis KM
    Contraception; 2017 Feb; 95(2):130-139. PubMed ID: 27771476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Type of Oral Anticoagulant Dispensed With Adverse Clinical Outcomes in Patients Extending Anticoagulation Therapy Beyond 90 Days After Hospitalization for Venous Thromboembolism.
    Pawar A; Gagne JJ; Gopalakrishnan C; Iyer G; Tesfaye H; Brill G; Chin K; Bykov K
    JAMA; 2022 Mar; 327(11):1051-1060. PubMed ID: 35289881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex matters: Practice 5P's when treating young women with venous thromboembolism.
    Bistervels IM; Scheres LJJ; Hamulyák EN; Middeldorp S
    J Thromb Haemost; 2019 Sep; 17(9):1417-1429. PubMed ID: 31220399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined hormonal contraception and the risk of venous thromboembolism: a guideline.
    ;
    Fertil Steril; 2017 Jan; 107(1):43-51. PubMed ID: 27793376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of recurrent venous thromboembolism among young women after a first event while exposed to combined oral contraception versus not exposed to: a cohort study.
    Le Moigne E; Delluc A; Tromeur C; Nowak E; Mottier D; Lacut K; Le Gal G
    Thromb Res; 2013 Jul; 132(1):51-5. PubMed ID: 23786893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH).
    Tosetto A; Iorio A; Marcucci M; Baglin T; Cushman M; Eichinger S; Palareti G; Poli D; Tait RC; Douketis J
    J Thromb Haemost; 2012 Jun; 10(6):1019-25. PubMed ID: 22489957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone-dependent gynaecological disorders and contraceptive modalities in women with a history of venous thromboembolic event: The THROMBOGYN study.
    Mottais-Cosnefroy V; Pecourt M; Yannoutsos A; Fels A; Beaussier H; Alran S; Priollet P; Hugon-Rodin J
    J Med Vasc; 2022; 47(5-6):228-237. PubMed ID: 36464417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined hormonal contraceptive use among women with known dyslipidemias: a systematic review of critical safety outcomes.
    Dragoman M; Curtis KM; Gaffield ME
    Contraception; 2016 Sep; 94(3):280-7. PubMed ID: 26272309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term risk of recurrent venous thromboembolism after a first contraceptive-related event: Data from REVERSE cohort study.
    Aziz D; Skeith L; Rodger MA; Sabri E; Righini M; Kovacs MJ; Carrier M; Kahn SR; Wells PS; Anderson DR; Chagnon I; Solymoss S; Crowther MA; White RH; Le Gal G
    J Thromb Haemost; 2021 Jun; 19(6):1526-1532. PubMed ID: 33724705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of a male or female thrombotic family history on contraceptive counseling: a cohort study.
    van Vlijmen EF; Veeger NJ; Middeldorp S; Hamulyák K; Prins MH; Kluin-Nelemans HC; Meijer K
    J Thromb Haemost; 2016 Sep; 14(9):1741-8. PubMed ID: 27327043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of cancer after anticoagulation in patients with unprovoked venous thromboembolism: an observational cohort study.
    Eischer L; Kammer M; Traby L; Kyrle PA; Eichinger S
    J Thromb Haemost; 2017 Jul; 15(7):1368-1374. PubMed ID: 28407356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcomes after discontinuing anticoagulant therapy in patients with first unprovoked venous thromboembolism.
    Gabara C; Aibar J; Nishimoto Y; Yamashita Y; Prandoni P; Barnes GD; Bikdeli B; Jiménez D; Demelo-Rodríguez P; Peris ML; Nguyen ST; Monreal M;
    J Thromb Haemost; 2024 Aug; 22(8):2234-2246. PubMed ID: 38762019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10.
    Lidegaard O; Nielsen LH; Skovlund CW; Løkkegaard E
    BMJ; 2012 May; 344():e2990. PubMed ID: 22577198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of recurrent venous thromboembolism after a first oestrogen-associated episode. Data from the REVERSE cohort study.
    Le Gal G; Kovacs MJ; Carrier M; Do K; Kahn SR; Wells PS; Anderson DA; Chagnon I; Solymoss S; Crowther M; Righini M; Lacut K; White RH; Vickars L; Rodger M
    Thromb Haemost; 2010 Sep; 104(3):498-503. PubMed ID: 20539910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of recurrence in women with venous thromboembolism related to estrogen-containing contraceptives: Systematic review and meta-analysis.
    Wiegers HMG; Knijp J; van Es N; Coppens M; Moll S; Klok FA; Middeldorp S
    J Thromb Haemost; 2022 May; 20(5):1158-1165. PubMed ID: 35108438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.